Key result
The presence of left ventricular thrombi after STEMI was independently associated with an increased risk of major adverse cardiac events at 1 year (HR 2.73; 95% CI 1.11-6.73; P=0.03).
Why the study?
Does the presence of left ventricular thrombus detected by cardiac magnetic resonance after STEMI increase the risk of major adverse cardiac events at 1 year?
Cohort (n=738)
Single-blind
Yes
Does the presence of left ventricular thrombus detected by cardiac magnetic resonance after STEMI increase the risk of major adverse cardiac events at 1 year?
Hazard Ratio: 2.73 (95% CI 1.11–6.73)
p-value: p=0.03
Left ventricular thrombus formation after STEMI, detected by CMR in 3.5% of patients, is independently associated with a nearly 3-fold increased risk of major adverse cardiac events at 1 year.
No takes yet. Share an insight, caveat, or question.
May warrant closer monitoring post-STEMI with LV thrombus; leaves open whether therapy modifies MACE risk.
Pöss et al. (2015) conducted a cohort in ST-segment-elevation myocardial infarction (STEMI) (n=738). Left ventricular thrombus vs. Absence of left ventricular thrombus was evaluated on occurrence of major adverse cardiac events within 1 year (HR 2.73, 95% CI 1.11-6.73, p=0.03). The presence of left ventricular thrombi after STEMI was independently associated with an increased risk of major adverse cardiac events at 1 year (HR 2.73; 95% CI 1.11-6.73; P=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: